HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Calls And Three Mexican Firms Recall Contaminated Sanitizers, But A Fourth Hangs Up

Executive Summary

Four warnings, like previous letters FDA submitted to Mexican firms making methanol-containing hand sanitizers, which have been linked to deaths and other adverse events, indicate the targeted firms apparently entered US market for the products after the agency loosened manufacturing controls.

You may also be interested in...

US Recalls: Bacteria Found On Scented Soaps From Firm Linked To Contaminated OTC Sanitizers

Scented soaps containing bacteria dangerous to people with weakened immune systems or chronic lung diseases are among recent US consumer health and beauty product recalls. More OTC sanitizers imported from Mexico and found to contain methanol and eye drops distributed without instructions also are on recall.

Claims Other Than COVID-19 Surface But Contaminated Sanitizer Spreads In US Warnings

FDA inspectors in the eastern US took their turn recently at finding violations for dietary supplement manufacturing marketing unrelated to COVID-19. Agency also warned two more Mexican businesses that exploited its temporary loosening of regulations for producing alcohol-based hand sanitizers.

US FDA Adds Hand Sanitizer Import Alert Category After COVID-19 Production Surge Turned Deadly

Action responds to methanol contamination in hand sanitizers manufactured in Mexico and marketed in the US under numerous brands that followed a loosening standards for the products to drive a swift increase in production and meet surging demand during the coronavirus pandemic.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts